This statistic shows the hemophilia A and B drug market size in leading markets worldwide in 2016 and a forecast for 2026 . In 2016 , the drug market size for hemophilia A and B was around 6.7 billion U.S. dollars and was expected to grow to some 8 billion dollars by 2026 .
